Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Starting soon Not applicable

Effect of Video Game-Based Breathing Exercises on Respiratory Dysfunction in ACOS

NCT07185178 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-10-10
Last updated
2026-10-06

Condition(s) studied

Asthma-COPD Overlap SyndromePulmonary RehabilitationVideo Games

Investigational drug(s) / intervention(s)

Video game-based breathing exercisesGroup 2:Telerehabilitation-based breathing exercises

Video game-based breathing exercises: İndividuals will be enrolled in the video game-based breathing exercise program. Participants in the study group will undergo the "Breathing Games" exercise program twice a week for 8 weeks, with each session lasting approximately 50 minutes. This video game-based breathing exercise program includes warm-up, cool-down, and five breathing games designed for the target patients.From the second week onward, posture exercises combined with the breathing games will be added.Thus, the exercise program will consist of a warm-up phase lasting approximately 10 minutes, including breathing control, stretching exercises, and rest; 25-30 minutes of five breathing games combined with posture exercises; followed by a cool-down phase of about 10 minutes with breathing control, stretching exercises, and rest.Additionally, participants will be provided with a home exercise program to be performed twice daily for 30 minutes, three days a week, over 8 weeks.

Group 2:Telerehabilitation-based breathing exercises: A telerehabilitation-based breathing exercise program will be administered to the control group with a frequency and duration similar to those of the intervention group (2 days per week, 8 weeks, 45-50 minutes/session). Session duration, total exercise time, home program, and interaction with the physiotherapist are planned similarly in both groups, aiming for the primary difference between groups to be solely the mode of delivery. In the control group, the level of interaction will be maintained by providing visual cues and real-time feedback during exercises. The telerehabilitation intervention will be conducted via the WhatsApp application on the patient's device. In addition, individuals will be prescribed a home exercise program to be performed 3 days a week, twice daily for 30 minutes, over the course of 8 weeks.

Study summary

Asthma and COPD are significant respiratory diseases that can coexist, referred to as Asthma-COPD Overlap Syndrome (ACOS). Patients with ACOS experience more severe clinical outcomes, including rapid decline in lung function, increased symptom burden, and reduced quality of life. Pulmonary rehabilitation-particularly breathing exercises-is a core non-pharmacological intervention recommended for this patient group. In recent years, video game-based applications have emerged as innovative tools that enhance motivation and participation in exercise programs. However, studies investigating the effects of video game-based breathing exercises in ACOS patients are extremely limited. Additionally, although dysfunctional breathing patterns are common in this group, few studies have addressed targeted interventions. The objective of the present study is to evaluate the effects of video game-based breathing exercises on dysfunctional breathing in ACOS patients.

Eligibility

Sex
ALL
Min age
40 Years
Max age
74 Years
Healthy volunteers
No
Inclusion Criteria: * Aged between 40 and 74 years * Diagnosed with Asthma-COPD Overlap Syndrome (ACOS) * Nijmegen Questionnaire score ≥ 23 * No severe asthma * No severe COPD * In a stable condition (no acute exacerbation in the last 4 weeks) * To have the cognitive level suitable to adapt to video games Exclusion Criteria: * Contraindicated for pulmonary rehabilitation * Diagnosed with cancer * Having severe cardiovascular disease * History of thoracic surgery * Presence of acute infectious disease * Cognitive impairment * Presence of vertigo, epilepsy, or visual impairment

Primary outcome measure(s)

  • Capnography — All assessments will be performed on the participants at the first session and repeated after 8 weeks.
    It will be used to evaluate whether ventilation is adequate and if the breathing pattern is appropriate. It is a monitoring device that continuously records the concentration of CO₂ in the exhaled gases during respiration graphically (in mmHg), providing information about the patient's respiratory rate per minute and the amount of CO₂ exhaled in each breath. It measures the partial pressure of CO₂ in the exhaled air, referred to as end-tidal CO₂ (ETCO₂), which is a reliable and time-sensitive clinical measurement of respiratory function. ETCO₂ shows good concurrent validity when compared directly with blood measurements. A value of 35 mmHg or below is commonly used as a cutoff point to define hypocapnia.

Trial sites (1)

FacilityCityRegionStatus
Kocaeli University Training and Research Hospital Kocaeli Izmit
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07185178 on ClinicalTrials.gov ↗ ← All trials in Turkey